Benjamin Yerxa

Dr. Benjamin R.
Yerxa is a President & Director at Opus Genetics, Inc. and a Chairman at RainBio, Inc. He is on the Board of Directors at Opus Genetics, Inc., Nacuity Pharmaceuticals, Inc., The North Carolina Biotechnology Center and Vedere Bio II, Inc. Dr. Yerxa was previously employed as an Independent Director by Clearside Biomedical, Inc., a Chief Executive Officer by Opus Genetics, Inc. /OLD/, a Chief Executive Officer by Retinal Degeneration Fund, a Chief Executive Officer by The Foundation Fighting Blindness, Inc., a President by Envisia Therapeutics, Inc., a Chief Scientific Officer by Liquidia Technologies, Inc., a Vice President-Research & Development by Clearside Biomedical, Inc., a Vice President-Product Development by Parion Sciences, Inc., an EVP, Chief Research & Development Officer by Inspire Pharmaceuticals, Inc., and a Research Scientist by Burroughs Wellcome.
He also served on the board at SparingVision SAS. He received his undergraduate degree from the University of California San Diego and a doctorate degree from the University of California, Irvine.